Allele-specific Expression of a Bitter Taste Receptor
Bitter Taste and Allele-specific Expression of the Human TAS2R38 Gene
1 other identifier
observational
57
1 country
3
Brief Summary
This single-site, within-subject experimental basic research study is designed to analyze the hypothesis that allele-specific expression of the bitter taste receptor T2R38 in taste tissue of individuals heterozygous for the taste receptor gene TAS2R38 correlates with that in nasal epithelium, and is responsible for differences in acyl-homoserine lactone-induced respiratory defenses. Subjects will include 100 predominantly European adults without chronic rhinosinusitis who will be undergoing a sinonasal procedure for reconstructive purposes. All subjects will provide saliva samples for genotyping, from which 25 subjects heterozygous for TAS2R38 (AVI/PAV) will be identified. These individuals will be asked to complete a beverage frequency questionnaire and taste test prior to the procedure that will evaluate for a number of compounds, among them bitter ligands specific to T2R38. Their tongue will also be photographed to evaluate the anatomy of their fungiform papillae, the mushroom-like structures on the tongue which contain taste buds. Subjects will subsequently provide nasal epithelium and taste tissue, which will be processed to 1) evaluate for allele-specific expression of TAS2R38 mRNA in both the taste and nasal tissue, with the nasal tissue concurrently being cultured in an air-liquid interface system to 2) assess the AHL-induced respiratory defenses of ciliary beat frequency (CBF) and nitric oxide (NO) production. Should subjects require a subsequent sinonasal procedure for clinically-determined reasons, taste and nasal tissue will again be obtained and analyzed for TAS2R38 mRNA, allowing for 3) longitudinal evaluation of mRNA expression level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2016
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 5, 2016
CompletedFirst Posted
Study publicly available on registry
May 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedSeptember 18, 2018
January 1, 2018
1.6 years
May 5, 2016
September 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
TAS2R38 genotype
A participant's genotype will be identified on enrollment in the study, the results of which could take up to 1 month to be performed.
Up to 1 month after enrollment.
TAS2R38 mRNA expression levels measured by RT-qPCR
Measured approximately 6 weeks after enrollment, based on the date of the participant's procedure.
Approximately 6 weeks after subject enrollment
Ciliary beat frequency
Measured approximately 6 weeks after enrollment, based on the date of the participant's procedure.
Approximately 6 weeks after subject enrollment
Production of nitric oxide by a participant's nasal epithelium culture measured in fold change of 4,5-diaminofluorescence diacetate
The production of nitric oxide (NO) by a patient's nasal epithelium culture will be measured approximately 6 weeks after enrollment, based on the date of his or her procedure. This will be measured by quantifying the fold change in fluorescence by using the NO-sensitive marker 4,5-diaminofluorescence diacetate (DAF-2).
Approximately 6 weeks after subject enrollment
Secondary Outcomes (3)
Bitter taste perception as measured by a visual analog scale
Approximately 6 weeks after subject enrollment
Caffeine intake measured by number caffeinated beverages consumed per week (normalized to 1 cup = 180 mg caffeine)
Approximately 6 weeks after subject enrollment
Taste papillae density
Approximately 6 weeks after subject enrollment
Study Arms (3)
PAV/PAV Tasters
Individuals homozygous for the taster allele of the TAS2R38 gene, PAV/PAV.
AVI/PAV.
Individuals heterozygous for the taster allele of the TAS2R38 gene, AVI/PAV.
AVI/AVI
Individuals homozygous for the non-taster allele of the TAS2R38 gene, AVI/AVI.
Interventions
Eligibility Criteria
One hundred subjects will be tested for TAS2R38 genotype. Our typical subject population is approximately 82% of European descent and 35% female. All subjects will be recruited from those seen in the department of otorhinolaryngology's rhinology division and planning to undergo a sinonasal procedure for reconstructive purposes. The initial interview will occur in the clinic setting. From these 100 subjects, 25 who are heterozygous for TAS2R38 will be asked to perform a taste test, complete a beverage frequency questionnaire, have their tongue photographed, and provide nasal epithelium and taste tissue during their procedure. Key exclusion criteria include a history of chronic rhinosinusitis, oral disease, and any condition that would prevent them from completing the psychophysical testing.
You may qualify if:
- English speaking, and plans to undergo a sinonasal procedure for reconstructive purposes or other reasons.
You may not qualify if:
- Plans to undergo a procedure for reasons other than reconstruction
- Oral disease
- Pregnancy, or any condition that would prevent psychophysical testing.
- Subjects showing signs of oral disease, including tongue lesions or xerostomia, would be excluded from tongue sampling, and therefore excluded from the study.
- Subjects will not be excluded because of economic status, gender, race or ethnicity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Monell Chemical Senses Centerlead
- University of Pennsylvaniacollaborator
- Corporal Michael J. Crescenz VA Medical Centercollaborator
Study Sites (3)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Monell Chemical Senses Center
Philadelphia, Pennsylvania, 19104, United States
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania, 19104, United States
Related Publications (19)
Drewnowski A, Gomez-Carneros C. Bitter taste, phytonutrients, and the consumer: a review. Am J Clin Nutr. 2000 Dec;72(6):1424-35. doi: 10.1093/ajcn/72.6.1424.
PMID: 11101467BACKGROUNDAdler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJ, Zuker CS. A novel family of mammalian taste receptors. Cell. 2000 Mar 17;100(6):693-702. doi: 10.1016/s0092-8674(00)80705-9.
PMID: 10761934BACKGROUNDChandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, Ryba NJ. T2Rs function as bitter taste receptors. Cell. 2000 Mar 17;100(6):703-11. doi: 10.1016/s0092-8674(00)80706-0.
PMID: 10761935BACKGROUNDLee RJ, Xiong G, Kofonow JM, Chen B, Lysenko A, Jiang P, Abraham V, Doghramji L, Adappa ND, Palmer JN, Kennedy DW, Beauchamp GK, Doulias PT, Ischiropoulos H, Kreindler JL, Reed DR, Cohen NA. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest. 2012 Nov;122(11):4145-59. doi: 10.1172/JCI64240. Epub 2012 Oct 8.
PMID: 23041624BACKGROUNDLee RJ, Kofonow JM, Rosen PL, Siebert AP, Chen B, Doghramji L, Xiong G, Adappa ND, Palmer JN, Kennedy DW, Kreindler JL, Margolskee RF, Cohen NA. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest. 2014 Mar;124(3):1393-405. doi: 10.1172/JCI72094. Epub 2014 Feb 17.
PMID: 24531552BACKGROUNDTizzano M, Gulbransen BD, Vandenbeuch A, Clapp TR, Herman JP, Sibhatu HM, Churchill ME, Silver WL, Kinnamon SC, Finger TE. Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3210-5. doi: 10.1073/pnas.0911934107. Epub 2010 Jan 26.
PMID: 20133764BACKGROUNDMueller KL, Hoon MA, Erlenbach I, Chandrashekar J, Zuker CS, Ryba NJ. The receptors and coding logic for bitter taste. Nature. 2005 Mar 10;434(7030):225-9. doi: 10.1038/nature03352.
PMID: 15759003BACKGROUNDBufe B, Breslin PA, Kuhn C, Reed DR, Tharp CD, Slack JP, Kim UK, Drayna D, Meyerhof W. The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Curr Biol. 2005 Feb 22;15(4):322-7. doi: 10.1016/j.cub.2005.01.047.
PMID: 15723792BACKGROUNDWooding S, Bufe B, Grassi C, Howard MT, Stone AC, Vazquez M, Dunn DM, Meyerhof W, Weiss RB, Bamshad MJ. Independent evolution of bitter-taste sensitivity in humans and chimpanzees. Nature. 2006 Apr 13;440(7086):930-4. doi: 10.1038/nature04655.
PMID: 16612383BACKGROUNDKim UK, Jorgenson E, Coon H, Leppert M, Risch N, Drayna D. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science. 2003 Feb 21;299(5610):1221-5. doi: 10.1126/science.1080190.
PMID: 12595690BACKGROUNDMennella JA, Pepino MY, Duke FF, Reed DR. Psychophysical dissection of genotype effects on human bitter perception. Chem Senses. 2011 Jan;36(2):161-7. doi: 10.1093/chemse/bjq106. Epub 2010 Oct 27.
PMID: 20980355BACKGROUNDLipchock SV, Mennella JA, Spielman AI, Reed DR. Human bitter perception correlates with bitter receptor messenger RNA expression in taste cells. Am J Clin Nutr. 2013 Oct;98(4):1136-43. doi: 10.3945/ajcn.113.066688. Epub 2013 Sep 11.
PMID: 24025627BACKGROUNDBartoshuk LM, Duffy VB, Miller IJ. PTC/PROP tasting: anatomy, psychophysics, and sex effects. Physiol Behav. 1994 Dec;56(6):1165-71. doi: 10.1016/0031-9384(94)90361-1.
PMID: 7878086BACKGROUNDDelwiche JF, Buletic Z, Breslin PA. Relationship of papillae number to bitter intensity of quinine and PROP within and between individuals. Physiol Behav. 2001 Oct;74(3):329-37. doi: 10.1016/s0031-9384(01)00568-6.
PMID: 11714496BACKGROUNDMelis M, Atzori E, Cabras S, Zonza A, Calo C, Muroni P, Nieddu M, Padiglia A, Sogos V, Tepper BJ, Tomassini Barbarossa I. The gustin (CA6) gene polymorphism, rs2274333 (A/G), as a mechanistic link between PROP tasting and fungiform taste papilla density and maintenance. PLoS One. 2013 Sep 9;8(9):e74151. doi: 10.1371/journal.pone.0074151. eCollection 2013.
PMID: 24040192BACKGROUNDMennella JA, Pepino MY, Duke FF, Reed DR. Age modifies the genotype-phenotype relationship for the bitter receptor TAS2R38. BMC Genet. 2010 Jul 1;11:60. doi: 10.1186/1471-2156-11-60.
PMID: 20594349BACKGROUNDPleis JR, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2007. Vital Health Stat 10. 2009 May;(240):1-159.
PMID: 19645319BACKGROUNDSuitor CJ, Gardner J, Willett WC. A comparison of food frequency and diet recall methods in studies of nutrient intake of low-income pregnant women. J Am Diet Assoc. 1989 Dec;89(12):1786-94.
PMID: 2592710BACKGROUNDSpielman AI, Pepino MY, Feldman R, Brand JG. Technique to collect fungiform (taste) papillae from human tongue. J Vis Exp. 2010 Sep 18;(42):2201. doi: 10.3791/2201.
PMID: 20972388BACKGROUND
Biospecimen
In part one of the study, each subject will provide a saliva sample. DNA will be isolated, purified, and quantitated for alleles of TAS2R38, a bitter taste receptor gene. Based on the results of the genetic screen, 25 individuals with the heterozygous genotype will be invited to return for part two of the study. In part two of the study, subject will provide nasal epithelium and taste tissue in the form of fungiform papillae. One half of each set of tissue will be placed in saline on ice in preparation for cell culture and assessment of AHL-induced defensive responses, while the second half will be placed in RNA preservative for mRNA isolation.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle R. Reed, Ph.D.
Monell Chemical Senses Center
- PRINCIPAL INVESTIGATOR
Noam A. Cohen, M.D., Ph.D.
Monell Chemical Senses Center, University of Pennsylvania
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2016
First Posted
May 10, 2016
Study Start
January 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 1, 2018
Last Updated
September 18, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share